These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2596130)

  • 21. Probucol treatment and thyroid function tests.
    Roach L; Botha A; Joffe BI; Baker SG; Shires R; Seftel HC
    S Afr Med J; 1980 Nov; 58(21):833. PubMed ID: 7444683
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effects of probucol on plasma cholesterol and triglyceride levels].
    Duarte GM; Lavall M
    Arq Bras Cardiol; 1981 Nov; 37(5):431-7. PubMed ID: 7347193
    [No Abstract]   [Full Text] [Related]  

  • 23. A symposium: new developments in the treatment of hypercholesterolemia--probucol. Introduction.
    Eder HA
    Am J Cardiol; 1986 Jun; 57(16):1H-2H. PubMed ID: 3728304
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of diet and probucol.
    Rapado A; Castrillo JM; Díaz-Curiel M
    Arch Intern Med; 1979 Sep; 139(9):1062-3. PubMed ID: 475528
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of probucol on the high density lipoprotein system in hypercholesterolaemic patients.
    Franceschini G; Calabresi L; Chiesa G; Vaccarino V; Sirtori M; Sirtori CR
    Pharmacol Res; 1989; 21(1):113-4. PubMed ID: 2726655
    [No Abstract]   [Full Text] [Related]  

  • 26. Effectiveness of individualized long-term therapy with niacin and probucol in reduction of serum cholesterol.
    Cohen L; Morgan J
    J Fam Pract; 1988 Feb; 26(2):145-50. PubMed ID: 3339318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mode of hypocholesterolemic action of probucol in animals and man.
    Beynen AC
    Artery; 1987; 14(2):113-26. PubMed ID: 3551883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Probucol and hypercholesterolaemia.
    Bateson MC; Fiabane AM; Clarke A; Bouchier IA
    Br J Clin Pharmacol; 1981 May; 11(5):531-3. PubMed ID: 7272170
    [No Abstract]   [Full Text] [Related]  

  • 29. Probucol and familial hypercholesterolemia.
    Dauignon J; Bouthillier D
    Can Med Assoc J; 1982 May; 126(9):1024-5. PubMed ID: 7074497
    [No Abstract]   [Full Text] [Related]  

  • 30. Probucol: a review of its pharmacological properties and therapeutic use in patients with hypercholesterolaemia.
    Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1978 Jun; 15(6):409-28. PubMed ID: 350557
    [No Abstract]   [Full Text] [Related]  

  • 31. Probucol in long-term treatment of hypercholesterolemia.
    Strandberg TE; Vanhanen H; Miettinen TA
    Gen Pharmacol; 1988; 19(3):317-20. PubMed ID: 3046993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Probucol versus eptastatin in hypercholesterolaemic diabetics.
    Yoshino G; Kazumi T; Uenoyama R; Inui A; Kasama T; Iwatani I; Iwai M; Yokono K; Otsuki M; Baba S
    Lancet; 1986 Sep; 2(8509):740-1. PubMed ID: 2876200
    [No Abstract]   [Full Text] [Related]  

  • 33. Probucol: effects on the metabolism of low density and high density lipoproteins in moderate hypercholesterolaemia.
    Magill P; Whiting C; Hammett F; Glick I; Miller NE; Lewis B
    Artery; 1982; 10(2):88-94. PubMed ID: 7092581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The probucol experience: a review of the past and a look at the future.
    Schwartz CJ
    Am J Cardiol; 1988 Jul; 62(3):1B-5B. PubMed ID: 3293414
    [No Abstract]   [Full Text] [Related]  

  • 35. Diet and drug synergism in treatment of hypercholesterolemia.
    Nutr Rev; 1978 Jan; 36(1):8-10. PubMed ID: 203877
    [No Abstract]   [Full Text] [Related]  

  • 36. Development of femoral atherosclerosis in hypercholesterolemic patients during treatment with cholestyramine and probucol/placebo: Probucol Quantitative Regression Swedish Trial (PQRST): a status report.
    Walldius G; Carlson LA; Erikson U; Olsson AG; Johansson J; Mölgaard J; Nilsson S; Stenport G; Kaijser L; Lassvik C
    Am J Cardiol; 1988 Jul; 62(3):37B-43B. PubMed ID: 3293415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A long-term (9 years) clinical study of the safety and efficacy of probucol, and an analysis of morbidity and mortality rates (author's transl)].
    Tedeschi RE; Martz BL; Taylor HA; Cerimelle BJ
    Nouv Presse Med; 1980 Oct; 9(40):3021-7. PubMed ID: 7003530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probucol in the long-term treatment of hypercholesterolaemia.
    Polachek AA; Katz HM; Sack J; Selig J; Littman ML
    Curr Med Res Opin; 1973; 1(6):323-30. PubMed ID: 4589404
    [No Abstract]   [Full Text] [Related]  

  • 39. Discrepancies between the outcome of animal and human studies on the mode of action of probucol.
    Beynen AC
    Atherosclerosis; 1986 Sep; 61(3):249-51. PubMed ID: 3768092
    [No Abstract]   [Full Text] [Related]  

  • 40. Biphenabid (Probucol): a new hypocholesterolemic agent.
    Kalams Z; Dacquisto M; Kornett GS
    Curr Ther Res Clin Exp; 1971 Nov; 13(11):692-4. PubMed ID: 5000716
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.